Article ID Journal Published Year Pages File Type
8815972 Journal of Affective Disorders 2018 31 Pages PDF
Abstract
Patients with BP-I experiencing an acute manic episode exhibited symptomatic and functional improvements during stabilization with oral aripiprazole and AOM 400 that were maintained with continued AOM 400 treatment but not placebo. AOM 400 is the first once-monthly long-acting injectable antipsychotic to demonstrate efficacy in maintenance treatment of the manic phase of BP-I.
Related Topics
Health Sciences Medicine and Dentistry Psychiatry and Mental Health
Authors
, , , , , , , , , , , ,